Adaptin Bio (APTN) Interest Coverage Ratio (2023 - 2026)

Adaptin Bio (APTN) reported Interest Coverage Ratio of 588.86 for Q1 2026, down 4930.93% on a YoY basis from 12.19 in Q1 2025, and down 2615.04% sequentially from 21.69 in Q4 2025.

Adaptin Bio (APTN) Interest Coverage Ratio (2023 - 2026) Analysis & Trends

Adaptin Bio (APTN) has 4 years of Interest Coverage Ratio data on file, last reported at 588.86 in Q1 2026.

  • For the quarter ending Q1 2026, Interest Coverage Ratio fell 4930.93% year-over-year to 588.86; the trailing twelve-month figure through Mar 2026 stood at 87.8 (down 952.69% YoY), and the FY2025 full-year result was 2.68, up 16.62% from the prior year.
  • Interest Coverage Ratio slipped to 588.86 in Q1 2026, from 21.69 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 0.96 in Q4 2023 to a low of 588.86 in Q1 2026.
  • A 4-year average of 82.41 and a median of 10.52 in 2024 frame the typical range for Interest Coverage Ratio.
  • Across the five-year window, Interest Coverage Ratio sank 54.49% in 2025 and tumbled 4930.93% in 2026, its largest moves.
  • Tracing APTN's Interest Coverage Ratio over 4 years: stood at 0.96 in 2023, then sank by 261.27% to 3.48 in 2024, then sank by 522.76% to 21.69 in 2025, then slumped by 2615.04% to 588.86 in 2026.
  • Business Quant data shows APTN's Interest Coverage Ratio at 588.86 in Q1 2026, 21.69 in Q4 2025, and 11.7 in Q1 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Mar 31, 2026 -588.86
Dec 31, 2025 -21.69
Mar 31, 2025 -11.70
Dec 31, 2024 -3.48
Sep 30, 2024 -9.34
Jun 30, 2024 -15.65
Mar 31, 2024 -7.58
Dec 31, 2023 -0.96